• / Free eNewsletters & Magazine
  • / My Account
Home>Sarepta Therapeutics CEO: We have just 100 doses to treat Ebola

Sarepta Therapeutics CEO: We have just 100 doses to treat Ebola

3party Content

Wed, 1 Oct 2014

On the heels of news of the first case of Ebola on U.S. soil, the company that has developed a treatment for the deadly disease said it has enough doses to cover about 100 patients. Shares of Sarepta Therapeutics Inc. (SRPT) shares rose 7% in late trade Tuesday after the confirmed a Dallas man was
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.